Prostate Cancer

Copyright 2006 by United Press International Recent News Randy Rhoads scholarship is increasedStudy: Soy nutrient reduces obesity riskHigh court hears military tribunal caseStudy: How sweet it is - or is it?

Longtime Newark mayor drops out of raceNymex crude rises nearly $2 per barrel Copyright © 2004-2006 DailyIndia.com Contact Us ...

Mice that did not receive genistein in utero were much heavier as adults - double the weight of their genistein-fed counterparts.

Prenatal genistein also shifted the offspring's coat color from yellow to brown, demonstrating that a single nutrient can have a widespread systemic impact, said the researchers.

Results of the study, funded by the National Institute of Environmental Health Sciences and the National Cancer Institute, appear in the April 1 issue of the journal Environmental Health Perspectives.

Other Headlines Politics & Policies: Israel goes to the pollsIsrael election vote to focus on peace process Analysis: Defections further strain inter-Korea tiesAnalysis: India seeking new approach to KashmirPacific island nations nervous about China's riseWalker's World: French unrest reveals deep dissatisfaction Copyright © 2006 News World Communications Inc.

Advertisers Advertisers ...

Mr.

Masraff wasn't giving up.

Instead he opted for "watchful waiting," a little-understood option for men with There's increasing evidence that watchful waiting is a safe option for 30 percent to 50 percent of men with newly diagnosed Several cancer centers are now conducting research to determine which patients are the best candidates for watchful waiting.

Last week University of Texas M.D.

Anderson Cancer Center announced a watchful-waiting study of 650 men that will also try to find molecular markers to help better predict risk.

This summer a multinational trial called START, supported in part by the U.S.

and Canadian National Cancer Institutes, will start recruiting 2,100 men to evaluate watchful waiting compared with other treatments.

To be sure, But in many men, the disease is slow-growing with little chance of ever causing problems.

"A lot of patients harbor these small areas" of cancer that don't pose a threat, says Laurence Klotz, professor of surgery at the University of Toronto and principle investigator on...